Literature DB >> 24269093

Ultrasonography of palm to elbow segment of median nerve in different degrees of diabetic polyneuropathy.

Hyun Im Moon1, Hee Kyu Kwon2, Lina Kim3, Hye Jin Lee4, Hang Jae Lee5.   

Abstract

OBJECTIVE: To identify the relationship between the ultrasonographic cross-sectional area (CSA) of the median nerve and electrophysiologic findings in diabetic patients.
METHODS: Sixty diabetic patients, 30 patients with carpal tunnel syndrome (CTS) and 30 healthy volunteers participated. The participants were divided into 4 groups: Control Group; Group I, diabetic patients without diabetic polyneuropathy (DPN); Group II, diabetic patients with DPN; and Group III, patients with CTS. Group II was subdivided into II-1 and II-2 according to DPN severity. The median nerve CSA was measured at 4 levels, and the wrist-to-forearm ratio (WFR) was calculated.
RESULTS: The median nerve CSAs were larger in Group II than in Group I and the Control Group. There were significant differences in the CSA between Group I and Group II-2 and between Group II-1 and II-2. There was no significant difference in the WFR among these groups. The CSAs at the wrist levels and WFR were significantly greater in Group III.
CONCLUSIONS: The median nerve CSA was greater in patients with DPN and was related to DPN severity. Diffuse increase in median nerve CSA without change in the WFR might be compatible with DPN. Ultrasonography could be applied for the diagnosis of DPN, especially in advanced cases. SIGNIFICANCE: Ultrasonography might have value in the differential diagnosis of DPN and entrapment neuropathy.
Copyright © 2013 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cross-sectional area; Diabetic polyneuropathy; Median nerve; Ultrasonography

Mesh:

Year:  2013        PMID: 24269093     DOI: 10.1016/j.clinph.2013.10.041

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

Review 1.  Entrapment neuropathies in diabetes mellitus.

Authors:  Eugenia Rota; Nicola Morelli
Journal:  World J Diabetes       Date:  2016-09-15

2.  Shear wave elastography evaluation of the median and tibial nerve in diabetic peripheral neuropathy.

Authors:  Ying He; Xi Xiang; Bi-Hui Zhu; Li Qiu
Journal:  Quant Imaging Med Surg       Date:  2019-02

3.  Morphological changes of the peripheral nerves evaluated by high-resolution ultrasonography are associated with the severity of diabetic neuropathy, but not corneal nerve fiber pathology in patients with type 2 diabetes.

Authors:  Fukashi Ishibashi; Miki Taniguchi; Rie Kojima; Asami Kawasaki; Aiko Kosaka; Harumi Uetake
Journal:  J Diabetes Investig       Date:  2014-11-27       Impact factor: 4.232

4.  Does Diabetes Mellitus Influence Carpal Tunnel Syndrome?

Authors:  Yoo Hwan Kim; Kyung Sook Yang; Hanjun Kim; Hung Youl Seok; Jung Hun Lee; Myeong Hun Son; Byung Jo Kim
Journal:  J Clin Neurol       Date:  2017-07       Impact factor: 3.077

5.  Carpal Tunnel Syndrome Assessment With Ultrasonography: A Comparison Between Non-diabetic and Diabetic Patients.

Authors:  Chung Ho Lee; Hanboram Choi; Joon Shik Yoon; Seok Kang
Journal:  Ann Rehabil Med       Date:  2018-02-28

6.  Electrodiagnostic Testing and Nerve Ultrasound of the Carpal Tunnel in Patients with Type 2 Diabetes.

Authors:  Bianka Heiling; Leonie I E E Wiedfeld; Nicolle Müller; Niklas J Kobler; Alexander Grimm; Christof Kloos; Hubertus Axer
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

7.  Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.

Authors:  Jia-Ying Sung; Jowy Tani; Tsui-San Chang; Cindy Shin-Yi Lin
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

8.  Diagnosis Accuracy of Carpal Tunnel Syndrome in Diabetic Neuropathy.

Authors:  Nicu Cătălin Drăghici; Maria Magdalena Tămaș; Daniel Corneliu Leucuța; Tudor Dimitrie Lupescu; Ștefan Strilciuc; Simona Rednic; Dafin Fior Mureșanu
Journal:  Medicina (Kaunas)       Date:  2020-06-05       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.